Cargando…
Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank
BACKGROUND: Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. The role of skeletal muscle mass in modulating immune response is well documented. Whilst obesity is well established as a key factor in COVID‐19 and outcome, no study...
Autores principales: | Wilkinson, Thomas J., Yates, Thomas, Baker, Luke A., Zaccardi, Francesco, Smith, Alice C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441916/ https://www.ncbi.nlm.nih.gov/pubmed/34541518 http://dx.doi.org/10.1002/rco2.47 |
Ejemplares similares
-
Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020) -
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study
por: Wilkinson, Thomas J., et al.
Publicado: (2021) -
Identification and Characterization of Genomic Predictors of Sarcopenia and Sarcopenic Obesity Using UK Biobank Data
por: Semenova, Ekaterina A., et al.
Publicado: (2023) -
Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
por: Yates, Thomas, et al.
Publicado: (2021) -
Multimorbidity and SARS-CoV-2 infection in UK Biobank
por: Chudasama, Yogini V., et al.
Publicado: (2020)